C ANN MERRIFIELD Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for C ANN MERRIFIELD.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of C ANN MERRIFIELD. C ANN MERRIFIELD is a Director in JUNIPER PHARMACEUTICALS INC ($JNP) and a Director in PLAYTEX PRODUCTS INC ($PYX) and a Director in INVIVO THERAPEUTICS HOLDINGS CORP. ($NVIV) and a Director in Flexion Therapeutics Inc ($FLXN).
Address: GENZYME GENETICS 15 PLEASANT STREET CONNECTOR FRAMINGHAM 01701-9322 MA
Companies in which C ANN MERRIFIELD is an Insider
Flexion Therapeutics Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of C ANN MERRIFIELD: Director
Holdings: 14,500 shares
Current Value: $276,080
Latest Transaction: Jun 12 2020
$FLXN Market Capitalization: $504.85M
$FLXN Previous Close: $19.04
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
INVIVO THERAPEUTICS HOLDINGS CORP.
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of C ANN MERRIFIELD: Director
Holdings: 3,639 shares
Current Value: $16,194
Latest Transaction: Mar 22 2021
$NVIV Market Capitalization: $139.34M
$NVIV Previous Close: $4.45
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
JUNIPER PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of C ANN MERRIFIELD: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Aug 15 2018
$JNP Market Capitalization: $53.67M
$JNP Previous Close: $4.97
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
PLAYTEX PRODUCTS INC
Industry: APPAREL & OTHER FINISHED PRODS OF FABRICS & SIMILAR MATERIAL [2300]
Position of C ANN MERRIFIELD: Director
Holdings: 14,500 shares
Latest Transaction: Jun 16 2005
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of C ANN MERRIFIELD
Sentiment: All, FLXN, NVIV, JNP, PYX
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 22 2021 | NVIV | INVIVO THERAPEUTIC ... | MERRIFIELD C ANN | Director | Option Exercise | A | 1.10 | 15,000 | 16,500 | 15,000 | |
| Jun 12 2020 | FLXN | Flexion Therapeuti ... | MERRIFIELD C ANN | Director | Option Exercise | A | 11.88 | 7,000 | 83,160 | 7,000 | |
| Jun 12 2020 | FLXN | Flexion Therapeuti ... | MERRIFIELD C ANN | Director | Grant | A | 0.00 | 4,500 | 0 | 14,500 | 10 K to 14.5 K (+45.00 %) |
| Mar 12 2020 | NVIV | INVIVO THERAPEUTIC ... | MERRIFIELD C ANN | Director | Option Exercise | P | 2.75 | 3,636 | 9,999 | 3,636 | |
| Mar 12 2020 | NVIV | INVIVO THERAPEUTIC ... | MERRIFIELD C ANN | Director | Buy | P | 0.00 | 3,636 | 0 | 3,639 | 3 to 3.6 K (+121,200.00 %) |
| Jun 21 2019 | FLXN | Flexion Therapeuti ... | MERRIFIELD C ANN | Director | Option Exercise | A | 11.74 | 12,500 | 146,750 | 12,500 | |
| May 24 2019 | FLXN | Flexion Therapeuti ... | MERRIFIELD C ANN | Director | Buy | P | 12.64 | 8,000 | 101,120 | 10,000 | 2 K to 10 K (+400.00 %) |